Search

Your search keyword '"Viktoria Hawryłkowicz"' showing total 2 results
Start Over Author "Viktoria Hawryłkowicz" Journal biomolecules
2 results on '"Viktoria Hawryłkowicz"'

1. The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)

Author

Dominika Maciejewska-Markiewicz, Ewa Stachowska, Viktoria Hawryłkowicz, Laura Stachowska, and Piotr Prowans

Subjects
NAFLD, n-3, PUFA, resolvins, protectins, marensins, Microbiology, QR1-502
Abstract

Increased triacylglycerols’ (TAG) synthesis, insulin resistance, and prolonged liver lipid storage might lead to the development of non-alcoholic fatty liver disease (NAFLD). Global prevalence of NAFLD has been estimated to be around 25%, with gradual elevation of this ratio along with the increased content of adipose tissue in a body. The initial stages of NAFLD may be reversible, but the exposition to pathological factors should be limited. As dietary factors greatly influence various disease development, scientists try to find dietary components, helping to alleviate the steatosis. These components include n-3 polyunsaturated (PUFA) fatty acids, especially eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA). This review focused on the role of resolvins, protectins and merensins in NAFLD.

Published
2021
Full Text
View/download PDF

2. The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)

Author

Ewa Stachowska, Laura Stachowska, Viktoria Hawryłkowicz, Dominika Maciejewska-Markiewicz, and Piotr Prowans

Subjects
0301 basic medicine, medicine.medical_specialty, Docosahexaenoic Acids, protectins, Adipose tissue, CD59 Antigens, Disease, Biochemistry, digestive system, Microbiology, n-3, resolvins, 03 medical and health sciences, 0302 clinical medicine, Insulin resistance, Non-alcoholic Fatty Liver Disease, Internal medicine, NAFLD, Fatty Acids, Omega-3, medicine, Animals, Humans, Molecular Biology, chemistry.chemical_classification, business.industry, Communication, Fatty liver, nutritional and metabolic diseases, medicine.disease, Eicosapentaenoic acid, digestive system diseases, QR1-502, Diet, 030104 developmental biology, Endocrinology, chemistry, Eicosapentaenoic Acid, Docosahexaenoic acid, 030220 oncology & carcinogenesis, marensins, lipids (amino acids, peptides, and proteins), Steatosis, Insulin Resistance, business, PUFA, Polyunsaturated fatty acid
Abstract

Increased triacylglycerols’ (TAG) synthesis, insulin resistance, and prolonged liver lipid storage might lead to the development of non-alcoholic fatty liver disease (NAFLD). Global prevalence of NAFLD has been estimated to be around 25%, with gradual elevation of this ratio along with the increased content of adipose tissue in a body. The initial stages of NAFLD may be reversible, but the exposition to pathological factors should be limited. As dietary factors greatly influence various disease development, scientists try to find dietary components, helping to alleviate the steatosis. These components include n-3 polyunsaturated (PUFA) fatty acids, especially eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA). This review focused on the role of resolvins, protectins and merensins in NAFLD.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results